Los Angeles Business Journal

FDA Unhappy with Kim Kardashian’s Posts

Wednesday, August 12, 2015

Reality TV star Kim Kardashian popularity on social media has become a problem for the Food and Drug Administration as a recent post in which she praised the pregnancy drug Diclegis, that she’s a paid spokesperson for, left out the its risks, the Los Angeles Times reports. The FDA has now ordered the prescription pill’s maker, Canada’s Duchesnay, to remove posts from several of Kardashian’s social media accounts. She has more than 100 million followers on Facebook, Twitter and Instagram.